Fibrin formation and proteolysis during ancrod treatment: Evidence for Des-A-profibrin formation and thrombin independent factor XIII activity

Annals of the New York Academy of Sciences

Volumn 936, Issue , 2001, Pages 210-214

  Dempfle, Carl Erik ^a   Argiriou, Sotiria ^a   Alesci, Sonja ^a   Kucher, Klaus ^b   Muller Peltzer H ^b   Rübsamen, Klaus ^b   Heene, Dieter L ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Knoll AG   (Germany)

Author keywords

Ancrod; DesA profibrin; Factor XIII; Fibrin formation; Proteolysis

Indexed keywords

ANCROD; BLOOD CLOTTING FACTOR 13; D DIMER; ENZYME PRECURSOR; FIBRIN DEGRADATION PRODUCT; FIBRIN DERIVATIVE; FIBRINOGEN; FIBRINOPEPTIDE A; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; VIPER VENOM;

CONFERENCE PAPER; FIBRIN FORMATION; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PLASMINOGEN ACTIVATION; PROTEIN CROSS LINKING; PROTEIN DEGRADATION;

CALLOSELASMA RHODOSTOMA; CROTALINAE; VIPER;

EID: 0034972780     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03507.x     Document Type: Conference Paper

References (14)

1. Therapeutic defibrination by ancrod (Arvin)
2. The proteolytic actions of ancrod on human fibrinogen and polypeptide chains
3. The action of Arvin on fibrin stabilizing factor (factor XIII)
4. Ancrod in the treatment of acute ischaemic stroke
5. Subcutaneous ancrod therapy in peripheral arterial disease: Improvement in blood viscosity and nutritional blood flow
6. Anticoagulant therapy with ancrod
7. Analysis of fibrin formation and proteolysis during intravenous administration of ancrod
8. Isolation and characterization of the fibrin intermediate arising from cleavage of one fibrinopeptide A from fibrinogen
9. The plasma factor XIII zymogen crosslinks fibrinogen
10. Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator
11. Proteolytic specificity of moojeni protease A isolated from the venom of Bothrops moojeni
12. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation
13. The fibin-solubilizing effect of fibrinogen as studied by light scattering
14. Influence of fibrinogen on fibrin polymerization. Ultracentrifugation studies